- Home
- CBAT vs PMVP Comparison
CBAT vs PMVP Comparison
Compare CBAT & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBAT
- PMVP
- Stock Information
- Founded
- CBAT 1999
- PMVP 2013
- Country
- CBAT China
- PMVP United States
- Employees
- CBAT N/A
- PMVP N/A
- Industry
- CBAT Industrial Machinery/Components
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- CBAT Miscellaneous
- PMVP Health Care
- Exchange
- CBAT Nasdaq
- PMVP Nasdaq
- Market Cap
- CBAT 90.4M
- PMVP 78.4M
- IPO Year
- CBAT N/A
- PMVP 2020
- Fundamental
- Price
- CBAT $0.93
- PMVP $1.40
- Analyst Decision
- CBAT
- PMVP Strong Buy
- Analyst Count
- CBAT 0
- PMVP 1
- Target Price
- CBAT N/A
- PMVP $5.00
- AVG Volume (30 Days)
- CBAT 191.6K
- PMVP 353.7K
- Earning Date
- CBAT 08-18-2025
- PMVP 08-07-2025
- Dividend Yield
- CBAT N/A
- PMVP N/A
- EPS Growth
- CBAT N/A
- PMVP N/A
- EPS
- CBAT N/A
- PMVP N/A
- Revenue
- CBAT $145,462,366.00
- PMVP N/A
- Revenue This Year
- CBAT N/A
- PMVP N/A
- Revenue Next Year
- CBAT $78.62
- PMVP N/A
- P/E Ratio
- CBAT N/A
- PMVP N/A
- Revenue Growth
- CBAT N/A
- PMVP N/A
- 52 Week Low
- CBAT $0.57
- PMVP $0.81
- 52 Week High
- CBAT $1.30
- PMVP $1.82
- Technical
- Relative Strength Index (RSI)
- CBAT 41.91
- PMVP 47.06
- Support Level
- CBAT $0.87
- PMVP $1.37
- Resistance Level
- CBAT $1.03
- PMVP $1.48
- Average True Range (ATR)
- CBAT 0.06
- PMVP 0.10
- MACD
- CBAT -0.00
- PMVP -0.02
- Stochastic Oscillator
- CBAT 27.27
- PMVP 13.22
About CBAT CBAK Energy Technology Inc.
CBAK Energy Technology Inc is engaged in the manufacture, commercialization, and distribution of a variety of standard and customized lithium and sodium high-power rechargeable batteries. The batteries are used in light electric vehicles, electric vehicles, energy storage devices, and other high-power applications. The company has two operating segments: CBAK, which derives maximum revenue, and includes the manufacturing, commercialization, and distribution of various standard and customized lithium-ion rechargeable batteries; and the Hitrans segment, which includes the development and manufacturing of NCM precursor and cathode materials. Geographically, the company derives its key revenue from Mainland China, followed by Europe and other regions.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.